Suppr超能文献

蛋白酪氨酸磷酸酶受体 δ 作为食欲素的受体发挥作用。

Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.

机构信息

Harrington Discovery Institute, Cleveland, OH, USA.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.

出版信息

Cell Metab. 2022 Apr 5;34(4):549-563.e8. doi: 10.1016/j.cmet.2022.02.012. Epub 2022 Mar 16.

Abstract

Asprosin is a fasting-induced glucogenic and centrally acting orexigenic hormone. The olfactory receptor Olfr734 is known to be the hepatic receptor for asprosin that mediates its effects on glucose production, but the receptor for asprosin's orexigenic function has been unclear. Here, we have identified protein tyrosine phosphatase receptor δ (Ptprd) as the orexigenic receptor for asprosin. Asprosin functions as a high-affinity Ptprd ligand in hypothalamic AgRP neurons, regulating the activity of this circuit in a cell-autonomous manner. Genetic ablation of Ptprd results in a strong loss of appetite, leanness, and an inability to respond to the orexigenic effects of asprosin. Ablation of Ptprd specifically in AgRP neurons causes resistance to diet-induced obesity. Introduction of the soluble Ptprd ligand-binding domain in the circulation of mice suppresses appetite and blood glucose levels by sequestering plasma asprosin. Identification of Ptprd as the orexigenic asprosin receptor creates a new avenue for the development of anti-obesity therapeutics.

摘要

脑肠肽激素 Asprosin 是一种饥饿诱导的产糖和中枢作用的食欲素。已知嗅觉受体 Olfr734 是 Asprosin 的肝受体,介导其对葡萄糖生成的作用,但 Asprosin 的食欲素功能的受体尚不清楚。在这里,我们确定蛋白酪氨酸磷酸酶受体 δ(Ptprd)是 Asprosin 的食欲素受体。Asprosin 在下丘脑 AgRP 神经元中作为高亲和力 Ptprd 配体发挥作用,以细胞自主的方式调节该回路的活性。Ptprd 的基因缺失会导致强烈的食欲减退、消瘦和无法对 Asprosin 的食欲素作用产生反应。特异性在 AgRP 神经元中缺失 Ptprd 会导致对饮食诱导肥胖的抵抗。将可溶性 Ptprd 配体结合域引入小鼠循环中,通过隔离血浆中的 Asprosin 来抑制食欲和血糖水平。鉴定出 Ptprd 是食欲素的 Asprosin 受体,为开发抗肥胖治疗药物开辟了新途径。

相似文献

1
Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.
Cell Metab. 2022 Apr 5;34(4):549-563.e8. doi: 10.1016/j.cmet.2022.02.012. Epub 2022 Mar 16.
2
Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue.
J Endocrinol. 2021 May;249(2):83-93. doi: 10.1530/JOE-20-0503.
3
Asprosin-neutralizing antibodies as a treatment for metabolic syndrome.
Elife. 2021 Apr 27;10:e63784. doi: 10.7554/eLife.63784.
4
Asprosin promotes feeding through SK channel-dependent activation of AgRP neurons.
Sci Adv. 2023 Feb 22;9(8):eabq6718. doi: 10.1126/sciadv.abq6718.
5
Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle.
J Cell Physiol. 2019 Nov;234(11):20888-20899. doi: 10.1002/jcp.28694. Epub 2019 Apr 17.
6
Energy Regulation Mechanism and Therapeutic Potential of Asprosin.
Diabetes. 2020 Apr;69(4):559-566. doi: 10.2337/dbi19-0009.
8
Asprosin is a centrally acting orexigenic hormone.
Nat Med. 2017 Dec;23(12):1444-1453. doi: 10.1038/nm.4432. Epub 2017 Nov 6.
9
Asprosin promotes β-cell apoptosis by inhibiting the autophagy of β-cell via AMPK-mTOR pathway.
J Cell Physiol. 2021 Jan;236(1):215-221. doi: 10.1002/jcp.29835. Epub 2020 Jun 18.

引用本文的文献

1
Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer.
Molecules. 2025 Aug 18;30(16):3410. doi: 10.3390/molecules30163410.
3
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health.
Rev Endocr Metab Disord. 2025 Jun 9. doi: 10.1007/s11154-025-09975-4.
4
Relationship between plasma asprosin, dry matter intake, and plasma glucose at different stages of lactation.
Front Vet Sci. 2025 May 21;12:1588671. doi: 10.3389/fvets.2025.1588671. eCollection 2025.
6
Whole-Genome Sequencing Reveals Individual and Cohort Level Insights into Chromosome 9p Syndromes.
medRxiv. 2025 Mar 30:2025.03.28.25324850. doi: 10.1101/2025.03.28.25324850.
7
The secretory function of adipose tissues in metabolic regulation.
Life Metab. 2024 Jan 20;3(2):loae003. doi: 10.1093/lifemeta/loae003. eCollection 2024 Apr.
9
The cerebellum modulates thirst.
Nat Neurosci. 2024 Sep;27(9):1745-1757. doi: 10.1038/s41593-024-01700-9. Epub 2024 Jul 10.
10
Asprosin: its function as a novel endocrine factor in metabolic-related diseases.
J Endocrinol Invest. 2024 Aug;47(8):1839-1850. doi: 10.1007/s40618-024-02360-z. Epub 2024 Apr 3.

本文引用的文献

2
Higher-Order Inputs Involved in Appetite Control.
Biol Psychiatry. 2022 May 15;91(10):869-878. doi: 10.1016/j.biopsych.2021.07.015. Epub 2021 Jul 24.
3
Revisiting energy expenditure: how to correct mouse metabolic rate for body mass.
Nat Metab. 2021 Sep;3(9):1134-1136. doi: 10.1038/s42255-021-00451-2.
4
Asprosin-neutralizing antibodies as a treatment for metabolic syndrome.
Elife. 2021 Apr 27;10:e63784. doi: 10.7554/eLife.63784.
5
The hypothalamus for whole-body physiology: from metabolism to aging.
Protein Cell. 2022 Jun;13(6):394-421. doi: 10.1007/s13238-021-00834-x. Epub 2021 Apr 7.
6
Asprosin in pregnancy and childhood.
Mol Cell Pediatr. 2020 Dec 23;7(1):18. doi: 10.1186/s40348-020-00110-8.
7
The Asprosin-OLFR734 module regulates appetitive behaviors.
Cell Discov. 2020 Apr 14;6:19. doi: 10.1038/s41421-020-0152-4. eCollection 2020.
8
The Protein Tyrosine Phosphatase Receptor Delta Regulates Developmental Neurogenesis.
Cell Rep. 2020 Jan 7;30(1):215-228.e5. doi: 10.1016/j.celrep.2019.11.033.
9
Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity.
Ann Nutr Metab. 2019;75(4):205-212. doi: 10.1159/000503808. Epub 2019 Nov 27.
10
De novo deleterious variants that may alter the dopaminergic reward pathway are associated with anorexia nervosa.
Eat Weight Disord. 2020 Dec;25(6):1643-1650. doi: 10.1007/s40519-019-00802-9. Epub 2019 Oct 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验